Exascale Labs Holdings Inc. — Form 8-K/A
Filed September 28, 2026 · analyzed by the 8-K Agent
8-K/A
▲ Likely positive
significance 62/100
What the filing says
On August 27, 2026, Exascale Labs Inc. merged with D. Boral ARC Acquisition I Corp. (BCAR) in a reverse recapitalization, with the combined company renamed Exascale Labs Holdings Inc. The merger valued Exascale at $500M (50M shares at $10/share). Exascale's revenue doubled from $7.0M (FY2025) to $14.8M (FY2026); net loss widened from $7.7M to $12.2M due to SAFE fair-value charges ($7.4M). All $29.1M in SAFEs were converted to PubCo Class A shares; combined entity retained $11.8M in post-deal cash. Company became publicly traded on Nasdaq (XLAB/XLABW) on August 28, 2026.
Why this rating
De-SPAC is material to $87.6M company; eliminates going-concern doubt. Revenue 111% growth strong but losses worsening, limiting optimism. Public markets access significant but dependent on execution.
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.